Cosmax BTI vs Altria Which Is Superior?

Cosmax BTI and Altria Group are two leading companies in the stock market with significant differences in their industries. Cosmax BTI, a biotechnology company, focuses on developing cutting-edge products in the health and wellness sector. On the other hand, Altria is a tobacco company that dominates the market with its iconic brands. Despite operating in different sectors, both companies have a strong presence in the stock market and offer investors unique opportunities for growth and profit.

Cosmax BTI or Altria?

When comparing Cosmax BTI and Altria, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Cosmax BTI and Altria.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Cosmax BTI has a dividend yield of 3.98%, while Altria has a dividend yield of 6.91%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Cosmax BTI reports a 5-year dividend growth of 0.00% year and a payout ratio of 31.38%. On the other hand, Altria reports a 5-year dividend growth of 5.06% year and a payout ratio of 66.57%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Cosmax BTI P/E ratio at 7.89 and Altria's P/E ratio at 9.49. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Cosmax BTI P/B ratio is 0.35 while Altria's P/B ratio is -28.15.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Cosmax BTI has seen a 5-year revenue growth of 0.43%, while Altria's is 0.11%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Cosmax BTI's ROE at 4.54% and Altria's ROE at -271.77%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ₩8670.00 for Cosmax BTI and $57.01 for Altria. Over the past year, Cosmax BTI's prices ranged from ₩8250.00 to ₩10730.00, with a yearly change of 30.06%. Altria's prices fluctuated between $39.25 and $58.04, with a yearly change of 47.87%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.